Inspire Medical Systems Reports Officer/Director Changes
Ticker: INSP · Form: 8-K · Filed: Jan 26, 2024 · CIK: 1609550
| Field | Detail |
|---|---|
| Company | Inspire Medical Systems, INC. (INSP) |
| Form Type | 8-K |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: officer-change, director-change, compensation
TL;DR
**Inspire Medical Systems filed an 8-K about officer changes, but no details yet.**
AI Summary
Inspire Medical Systems, Inc. filed an 8-K on January 26, 2024, reporting an event that occurred on January 22, 2024. This filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' and 'Financial Statements and Exhibits'. While the filing confirms these categories, it does not provide specific names, dollar amounts, or detailed changes. For investors, this matters because changes in leadership or executive compensation can signal shifts in company strategy or financial health, but without specifics, the impact remains unclear.
Why It Matters
Changes in executive leadership or compensation can impact a company's strategic direction and financial performance, directly affecting shareholder value.
Risk Assessment
Risk Level: low — The filing indicates a change in officer/director status but lacks specific details that would suggest a high or medium risk.
Analyst Insight
Investors should monitor future filings or company announcements for specific details regarding the reported officer/director changes and compensatory arrangements, as this filing provides no actionable specifics.
Key Players & Entities
- Inspire Medical Systems, Inc. (company) — the registrant filing the 8-K
- January 22, 2024 (date) — date of the earliest event reported
- January 26, 2024 (date) — date the 8-K was filed
- 001-38468 (other) — Commission File Number
- INSP (other) — Trading Symbol for Common Stock
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 22, 2024.
What specific items were reported in this 8-K filing by Inspire Medical Systems, Inc.?
Inspire Medical Systems, Inc. reported 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' and 'Financial Statements and Exhibits' under Item Information.
What is the trading symbol and exchange for Inspire Medical Systems, Inc.'s Common Stock?
The trading symbol for Inspire Medical Systems, Inc.'s Common Stock is INSP, and it is registered on the New York Stock Exchange.
What is the business address of Inspire Medical Systems, Inc.?
The business address of Inspire Medical Systems, Inc. is 5500 Wayzata Blvd., Suite 1600, Golden Valley, Minnesota 55416.
What is the Commission File Number for Inspire Medical Systems, Inc.?
The Commission File Number for Inspire Medical Systems, Inc. is 001-38468.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 9.4 · Accepted 2024-01-26 16:17:30
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share INSP New York Stock
Filing Documents
- insp-20240122.htm (8-K) — 27KB
- jerrygriffinpr2024-01x26.htm (EX-99.1) — 7KB
- new20logo20on20whitea.jpg (GRAPHIC) — 35KB
- 0001609550-24-000008.txt ( ) — 208KB
- insp-20240122.xsd (EX-101.SCH) — 2KB
- insp-20240122_lab.xml (EX-101.LAB) — 24KB
- insp-20240122_pre.xml (EX-101.PRE) — 13KB
- insp-20240122_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Inspire Medical Systems, Inc., dated January 2 6, 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIRE MEDICAL SYSTEMS, INC. Date: January 26, 2024 By: /s/ Bryan K. Phillips Bryan K. Phillips Sr. Vice President, General Counsel 3